Fibronectin extra domain A as a drug delivery targeting epitope for rheumatoid arthritis
Abstract Objectives To assess the ability of monoclonal antibodies (mAbs) specific for fibronectin extra-domain A (FnEDA) to target diseased tissues of mouse collagen induced arthritis (mCIA) models. To explore the parameters of the targeting exhibited by anti-FnEDA mAbs including timing and locatio...
Main Authors: | Victor Z. Sun, Terry L. Melim, Soumya Mitra, Jamie E. Erickson, Shaughn H. Bryant, Avery Farnham, Susan Westmoreland, Heather Knight, Liang Zhang, Wendy Ritacco, Kristoff Homan, Lorenzo Benatuil, Annette J. Schwartz Sterman, Andrew D. Goodearl |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-05-01
|
Series: | Advances in Rheumatology |
Online Access: | https://doi.org/10.1186/s42358-022-00247-2 |
Similar Items
-
C6: A Monoclonal Antibody Specific for a Fibronectin Epitope Situated at the Interface between the Oncofoetal Extra-Domain B and the Repeat III8.
by: Elisa Ventura, et al.
Published: (2016-01-01) -
Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells
by: Felipe Prosper, et al.
Published: (2022-08-01) -
CAR-T-Cell Therapy for Solid Tumors Positive for Fibronectin Extra Domain B
by: Zhijie Zhang, et al.
Published: (2022-09-01) -
Human fibronectin extra domain B as a biomarker for targeted therapy in cancer
by: Relinde I. Y. Lieverse, et al.
Published: (2020-07-01) -
Fibronectin Extra Domain A Promotes Liver Sinusoid Repair following Hepatectomy.
by: Bridget Sackey-Aboagye, et al.
Published: (2016-01-01)